Exactly why this must be consumer driven. The patient actually has to want it and ask their Doctor for it by name in most cases. It used to drive me nuts when I would hear a Doctor talk to people about weight and yet they are as you say fat themselves. The patient can't take someone like that serious. Word of mouth and a MASSIVE consumer awareness campaign is what will make Belviq a success.
Bad weather, seasonality, holidays, road construction ect..........
I pretty much agree. There was someone basically trying to start a petition around here not so long ago. I responded with the following.
"The SEC has probably had it up to their ears with complaints from some on this board. They would also probably need to hire someone full time just to respond to Arena shareholders. Heck they may even have a program blocking anything pertaining to Arena so they can do some real work. The Sec is not in the business of telling folks what they can and cannot invest in"
He failed to persuade anyone. That may be him covering his short.
I was going to post it on the other company's board in the space we are in (assuming your still in) but decided not to until we get a decision. It clearly mentions all the procedures (gastric, lap band, pills) as tools needed to combat obesity. The gap in the innovation space will make it a success if approved or at least i hope so anyway. Not to mention it sounds like it works just as well as pills do. Different target audience though.
We have all had our moments. With that said It would only be a victory for shorts and fudsters.
In Israel suffers from as well fifty percent of the adult population in the country is overweight or obese. The overweight rate is 50% higher among men
Among Jewish men, the highest rates of obesity and overweight are in the 45-64 age group, where they reach 70% of the population. Sixty-four percent of Jewish women aged 65 and over are overweight or obese.
Population: 7 Million
Management of Obesity in Adults being circulated to thousands of Family practice Doctors across the Country. Follow the link below for 33 pages of good stuff. All the drugs in the space mentioned in great detail.
We should get earnings in the next few weeks. We may or may not though get a Q&A session being that we are still waiting for a decision. I suspect we will hear something from the FDA by October but your guess would be as good as mine. Before the end of the year for sure. GL and by the way I would be buying to if it falls to those levels again.
That's scary Tiger. As Sharon noted it is the advisory board which i knew. But why would Eisai more importantly jack even allow such a thing? Maybe i'm reading to much into it but it doesn't sound to me anyway like a good idea. That be like someone on the inside advising Pepsi sitting in on the coke board.
Why do I post, because I can! I am over it and did sell, but it doesn't mean I can't still be interested in what's happening. There is a real good chance I will eventually be getting back in under my terms not yours. The reason for the post is because I was doing some research when I stumbled onto the FACT "Donna Ryan" sits on the advisory board of Eisai, and all of our competitors Vivus and Takeda who is Orex partner. I guess it may not be a big deal if they weren't all competing in the obesity space/race. So I guess what you're saying is creating a new post with a legitimate concern is now bashing. You must not have seen the question mark. I was looking for someone to tell me it was nothing to worry about and their theory behind it. But you couldn't do that. All you want to do is follow people's post and tell them how all things are hunky dory and you can wait 5 years. Do you know how ridiculous that sounds? Chances are Swalchie you invested in Arena because of Belviq NOT the pipeline.
Your long Swalchie do you not find this odd?
Jack has made it clear in the past due to strategic planning they don't want to divulge to much information keeping their competitors in limbo. But now it's okay for Mrs Ryan to sit on the board of Eisai and ALL of their competitors? Get you head out of you rear end there Pal!
Donna H. Ryan, MD discloses that she is on the advisory boards for Eisai Inc.; Janssen Pharmaceuticals, Inc.; Novo Nordisk, Inc.; Takeda Pharmaceuticals U.S.A., Inc.; and VIVUS, Inc. Dr. Ryan has ownership interest in Scientific Intake. How could this even be possible? I wonder if jack knows.
So i wonder how SO will spin this one. He has clearly said in the past on multiple occasions the IMS 10,000 mark would be the tipping point and drive new institutional investors into the stock.
There's really nothing for them to say at this point. They are basically in a quite period. So not to jeopardize what seems like is going to be approval shortly it's better to just not say anything else until then. An insider spoke loud and clear though by making a stock purchase after the positive vote.
I haven't been paying as close attention lately as I used to, but he did call this rebound to $5 just a couple a days ago from the $4.70's
I cannot help but laugh at 99% of your post. That means I never put you on ignore! You are full of good info and good for laughs!
This is very worthy of a PR and exactly the kind of news that could easily put the hurting to the "dwindling" shorts. I know it's just a patent and still way to early to make much of it but having followed cannabis stocks for awhile I've seen what they can do. The mere mention of it in a PR could put Millions of new dollars to work! Probably worth more to shareholders to spend a few bucks on a PR then traveling expenses to the next conference. Most people have no idea what Arena is holding in the bag. So why not throw out a PR while the subject is "HOT" get people doing their DD, let them see the hundreds of patents involved and hopefully put their money to work.
"Why isn't it trading at $10 yet" Well first of all it has yet to be approved and I never said it was going to $10. I can only speak from past experience from being invested in the obesity space for the past several years. Let me remind you Arena was sitting around these levels before approval then spiked to $13 briefly on a short squeeze before settling around $8 for a while. The weight loss pills shouldn't even be mentioned when comparing this devise to them. This devise and the different procedures already available are for the morbidly obese which pills aren't going to help.